{
  "resourceType" : "ValueSet",
  "id" : "2.16.840.1.113762.1.4.1196.96",
  "meta" : {
    "versionId" : "6",
    "lastUpdated" : "2023-12-21T17:43:03.000-05:00",
    "profile" : [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension" : [
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueString" : "Elimu Informatics Author"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate" : "2024-02-14"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate" : "2019-05-11"
    }
  ],
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.96",
  "identifier" : [
    {
      "system" : "urn:ietf:rfc:3986",
      "value" : "urn:oid:2.16.840.1.113762.1.4.1196.96"
    }
  ],
  "version" : "20190511",
  "name" : "CPICRxNORMAtazanavirSCDG",
  "title" : "CPIC RxNORM atazanavir SCDG",
  "status" : "active",
  "experimental" : false,
  "date" : "2019-05-11T01:00:10-04:00",
  "publisher" : "Elimu Informatics Steward",
  "description" : "We have NOT excluded any dose forms (such as topical), at this time, even though in some cases topical medications may not be subject to the same drug-gene interactions that are seen with systemically administered medications.\nElimu OID: 2019.05.14.10.51",
  "jurisdiction" : [
    {
      "coding" : [
        {
          "system" : "urn:iso:std:iso:3166",
          "code" : "US"
        }
      ]
    }
  ],
  "purpose" : "(Clinical Focus: This value set contains all RxNorm codes of type Semantic Clinical Dose Form Group (TTY=SCDG) having atazanavir as an ingredient.),(Data Element Scope: None),(Inclusion Criteria: This value set contains all RxNorm codes of type Semantic Clinical Dose Form Group (TTY=SCDG) having atazanavir as an ingredient.),(Exclusion Criteria: None)",
  "compose" : {
    "include" : [
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "concept" : [
          {
            "code" : "1154364",
            "display" : "Atazanavir Oral Product"
          },
          {
            "code" : "1154365",
            "display" : "Atazanavir Pill"
          },
          {
            "code" : "1598983",
            "display" : "Atazanavir Oral Powder Product"
          },
          {
            "code" : "1601650",
            "display" : "Atazanavir / cobicistat Oral Product"
          },
          {
            "code" : "1601651",
            "display" : "Atazanavir / cobicistat Pill"
          }
        ]
      }
    ]
  },
  "expansion" : {
    "identifier" : "urn:uuid:50540518-b6b8-495c-bc83-c1c8b11511d0",
    "timestamp" : "2024-06-14T13:17:59-04:00",
    "total" : 5,
    "contains" : [
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "05062024",
        "code" : "1154364",
        "display" : "atazanavir Oral Product"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "05062024",
        "code" : "1154365",
        "display" : "atazanavir Pill"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "05062024",
        "code" : "1598983",
        "display" : "atazanavir Oral Powder Product"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "05062024",
        "code" : "1601650",
        "display" : "atazanavir / cobicistat Oral Product"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "05062024",
        "code" : "1601651",
        "display" : "atazanavir / cobicistat Pill"
      }
    ]
  }
}
